Livongo Health Q3 Adj. EPS $0.16 Beats $0.05 Estimate, Sales $106.10M Beat $98.80M Estimate
Livongo Health Q3 Adj. EPS $0.16 Beats $0.05 Estimate, Sales $106.10M Beat $98.80M Estimate
Livongo Health 第三季度調整後每股收益0.16美元超過預期0.05美元，銷售額1.0610億美元超過9,880萬美元的預期
Livongo Health (NASDAQ:LVGO) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.05 by 220 percent. This is a 420 percent increase over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $106.10 million which beat the analyst consensus estimate of $98.80 million by 7.39 percent. This is a 127.40 percent increase over sales of $46.66 million the same period last year.
Livongo Health（納斯達克：LVGO）公佈的季度每股收益爲0.16美元，比分析師共識估計的0.05美元高出220％。這比去年同期每股虧損0.05美元（0.05美元）增加了420％。該公司公佈的季度銷售額爲1.0610億美元，比分析師共識估計的9,880萬美元高出7.39％。這比去年同期的4,666萬美元銷售額增長了127.40％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。